Education and Training
- M.S., University of North Carolina at Chapel Hill, 1979
- B.S., East Carolina University, 1977
LaFayette, SL, Collins, C, Zaas, AK, Schell, WA, Betancourt-Quiroz, M, Gunatilaka, AAL, Perfect, JR, and Cowen, LE. "PKC signaling regulates drug resistance of the fungal pathogen Candida albicans via circuitry comprised of Mkc1, calcineurin, and Hsp90." Plos Pathogens 6, no. 8 (August 26, 2010): e1001069-null.
Wulff-Burchfield, E, Schell, WA, Eckhardt, AE, Pollack, MG, Hua, Z, Rouse, JL, Pamula, VK, Srinivasan, V, Benton, JL, Alexander, BD, Wilfret, DA, Kraft, M, Cairns, CB, Perfect, JR, and Mitchell, TG. "Microfluidic platform versus conventional real-time polymerase chain reaction for the detection of Mycoplasma pneumoniae in respiratory specimens." Diagnostic Microbiology and Infectious Disease 67, no. 1 (May 2010): 22-29.
Hua, Z, Rouse, JL, Eckhardt, AE, Srinivasan, V, Pamula, VK, Schell, WA, Benton, JL, Mitchell, TG, and Pollack, MG. "Multiplexed real-time polymerase chain reaction on a digital microfluidic platform." Anal Chem 82, no. 6 (March 15, 2010): 2310-2316.
Singh, SD, Robbins, N, Zaas, AK, Schell, WA, Perfect, JR, and Cowen, LE. "Hsp90 governs echinocandin resistance in the pathogenic yeast Candida albicans via calcineurin." Plos Pathogens 5, no. 7 (July 31, 2009): e1000532-null.
Cowen, LE, Singh, SD, Köhler, JR, Collins, C, Zaas, AK, Schell, WA, Aziz, H, Mylonakis, E, Perfect, JR, Whitesell, L, and Lindquist, S. "Harnessing Hsp90 function as a powerful, broadly effective therapeutic strategy for fungal infectious disease." Proceedings of the National Academy of Sciences of the United States of America 106, no. 8 (February 5, 2009): 2818-2823.
Bidartondo, MI. "Preserving accuracy in GenBank." Science (New York, N.Y.) 319, no. 5870 (March 2008): 1616-null. (Letter)
Onyewu, C, Eads, E, Schell, WA, Perfect, JR, Ullmann, Y, Kaufman, G, Horwitz, BA, Berdicevsky, I, and Heitman, J. "Targeting the calcineurin pathway enhances ergosterol biosynthesis inhibitors against Trichophyton mentagrophytes in vitro and in a human skin infection model." Antimicrobial Agents and Chemotherapy 51, no. 10 (October 2007): 3743-3746.
Espinel-Ingroff, A, Fothergill, A, Ghannoum, M, Manavathu, E, Ostrosky-Zeichner, L, Pfaller, MA, Rinaldi, MG, Schell, W, and Walsh, TJ. "Quality control and reference guidelines for CLSI broth microdilution method (M38-A document) for susceptibility testing of anidulafungin against molds." Journal of Clinical Microbiology 45, no. 7 (July 2007): 2180-2182.
Smith, PB, Steinbach, WJ, Cotten, CM, Schell, WA, Perfect, JR, Walsh, TJ, and Benjamin, DK. "Caspofungin for the treatment of azole resistant candidemia in a premature infant." Journal of Perinatology : Official Journal of the California Perinatal Association 27, no. 2 (February 2007): 127-129.
Guarro, J, Severo, LC, Gené, J, Oliveira, FDM, Cano, J, Franche, G, Cantarelli, VV, and Schell, WA. "Sinusitis caused by the fungus Xylaria enteroleuca in a lung transplant recipient." Diagnostic Microbiology and Infectious Disease 56, no. 2 (2006): 207-212.